Ann Dewitt

Verified
General Partner at Engine VenturesListed on SEC Form ADVCambridge, United States
Claim this profile
Sign up to save
Cool

Check Size

Not yet known

Reliability Score

🎯83% of deals in Healthcare
📈2.0x more deals in 2021 vs 2020

Investment Timeline

Droplet Biosciences
Board seat (SEC Form D)Source
Since May 2021
Company last raised Dec 2023
Vaxess Technologies
Board seat (SEC Form D)Source
Since Mar 2021
Company last raised Mar 2026
Quaise Energy
Board seat (SEC Form D)Source
Since Jun 2020
Company last raised Sep 2026
E25Bio
Board seat (SEC Form D)Source
Since Aug 2019
Company last raised Jun 2021
Lucy Therapeutics
Board seat (SEC Form D)Source
Since Jul 2019
Company last raised May 2024
Kytopen
Board seat (SEC Form D)Source
Since May 2019
Company last raised Feb 2025

Portfolio Breakdown

By Sector

Healthcare5 deals · 83%
Other Energy1 deal · 17%

By Stage

6 tracked deals2 sectors · 0 stages

Deal Velocity

Avg Deals / Year
2.0
Avg Deal Size
Unknown
Largest Deal
Droplet Biosciences
Unknown
YoY Trend
Accelerating

Deals Per Year

3
19
1
20
2
21
6 total deals tracked2019–2021

Investment Activity Map

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2019
2020
2021
Less
More

Current Fund Status

Fund Name
The Engine Fund I Spv-C, LLC
Reported Size
$10.0M

Co-Investors

No co-investment data available yet.

Warm Intro Paths

Sign in to discover warm intro paths

Sign in